Human bone marrow mesenchymal progenitors: perspectives on an optimized in vitro manipulation
Open Access
- 27 March 2014
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
- Vol. 2, 7
Abstract
When it comes to regenerative medicine, mesenchymal stem cells (MSCs) are considered one of the most promising cell types for use in many cell therapies and bioengineering protocols. The International Society of Cellular Therapy recommended minimal criteria for defining multipotential MSC is based on adhesion and multipotency in vitro, and the presence or absence of select surface markers. Though these criteria help minimize discrepancies and allow some comparisons of data generated in different laboratories, the conditions in which cells are isolated and expanded are often not considered. Herein, we propose and recommend a few procedures to be followed to facilitate the establishment of quality control standards when working with mesenchymal progenitors isolation and expansion. Following these procedures, the classic Colony-Forming Unit-Fibroblast (CFU-f) assay is revisited and three major topics are considered to define conditions and to assist on protocol optimization and data interpretation. We envision that the creation of a guideline will help in the identification and isolation of long-term stem cells and short-term progenitors to better explore their regenerative potential for multiple therapeutic purposes.Keywords
This publication has 69 references indexed in Scilit:
- The Tunica Adventitia of Human Arteries and Veins As a Source of Mesenchymal Stem CellsStem Cells and Development, 2011
- Prospective Identification and Skeletal Localization of Cells Capable of Multilineage Differentiation In VivoStem Cells and Development, 2010
- Explant Outgrowth, Propagation and Characterization of Human PericytesMicrocirculation, 2010
- Human Mesenchymal Stem Cells Self-Renew and Differentiate According to a Deterministic HierarchyPLOS ONE, 2009
- Enumeration of the colony-forming units–fibroblast from mouse and human bone marrow in normal and pathological conditionsStem Cell Research, 2009
- A Perivascular Origin for Mesenchymal Stem Cells in Multiple Human OrgansCell Stem Cell, 2008
- Optimization of in vitro expansion of human multipotent mesenchymal stromal cells for cell‐therapy approaches: Further insights in the search for a fetal calf serum substituteJournal of Cellular Physiology, 2006
- Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statementCytotherapy, 2006
- The SH-3 and SH-4 Antibodies Recognize Distinct Epitopes on CD73 from Human Mesenchymal Stem CellsBiochemical and Biophysical Research Communications, 2001
- The Monoclonal Antibody SH-2, Raised against Human Mesenchymal Stem Cells, Recognizes an Epitope on Endoglin (CD105)Biochemical and Biophysical Research Communications, 1999